Gapping up
In reaction to strong earnings/guidance: TSLA +12.1%, IMAX +9.8%, DL +9.4% (light volume), AWAY +9.4%, PRAA +8.5% (also agrees to acquire Aktiv Kapital for $880 mln, while also agreeing to assume ~$435 mln of its corporate debt, resulting in an acquisition of estimated total enterprise value of $1.3 bln; expected to be immediately accretive to earnings), AVG +7.5%, TRN+4.5%, MONT +4%, ASGN +3.9%, JACK +3.6%, VECO +3.5%, SWY +3.4%, (also following late spike on PE speculation; confirmed discussions concerning a possible transaction involving the sale of co; plans to distribute Blackhawk shares to stockholders; also exploring monetization of its ownership in Casa Ley), WLT +3.1%, EIG +2.9%, ( downgraded to Mkt Underperform from Mkt Perform at JMP Securities), ARRS +2.4%, (light volume), AMTG +2.2%, (light volume), UPL +2%, HRL +2%, (ticking higher), CSGP +1.8%, MCHX +1.8%, (light volume), TRAK +1.6% (also upgraded to Outperform from Market Perform at Wells Fargo), WLK +1.6%, (light volume), EQIX +1.2%, (also downgraded to Neutral from Overweight at Piper Jaffray), ACT +1.2%.
M&A news: JNPR +2.9% (Nokia considering acquisition of JNPR, according to reports ).
Select oil/gas related names showing strength: SNP +2.9%, DO +1.6%, COP +1.0%, BP +1%, RDS.A +0.6%, SDRL +0.6%, PBR +0.6%, CVX +0.4%.
A few biotech/pharma names are higher: MRK +1.1%, AZN +1%, BMY +1.0%, GSK +1.0%
FB/WhatsApp news lifting select tech names/peers: MEET +13.1% BBRY +4.9% TWTR +0.5%
Other news: RPTP +7.2% (Announces Clinical Results With RP103 in Huntington's Disease Phase 2/3 Trial; 18 Month Clinical Results Showed Significantly Slower Progression of Total Motor Score in RP103 Treated Patients Without Tetrabenazine), ATRS +5.5% (announces positive results from the VIBEX QuickShot pharmacokinetic study in testosterone deficient men; rapid restoration and consistent maintenance of steady testosterone blood levels achieved with once-weekly subcutaneous administration using the QuickShot auto injector), KNDI +4.1% (TSLA sympathy), VE +3.3% (Veolia Environnement higher on contract win news), GRPN +2.8% (ahead of earnings after the close), SCTY +2.6% (TSLA/Musk sympathy), OMG +1.7% (OM Group company EaglePicher Technologies receives contract from Erigo Technologies to deliver a Flexible Microgrid Energy Storage System for DoD applications), SVU +1.3% (following SWY results and news), WRB +0.6% (increases share repurchase authorization back to its previous level of 10 mln shares of common stock), ALL +0.6% (increases quarterly dividend 12% to $0.28 from $0.24 per share; launches $2.5 bln common stock repurchase program), PCLN +0.5% and CTRP +0.5% (following AWAY results), NXPI +0.4% (repurchases 5 mln shs of common stock ), KR +0.3% (following SWY results and news).
Analyst comments: BLOX +3.2% (upgraded to Buy from Neutral at Goldman), BCRX +2.8% (initiated with a Buy at Mizuho; tgt $23 ), HSTM +1.4% (upgraded to Overweight from Equal Weight at First Analysis), G +1.3% (initiated with an Overweight at Piper Jaffray), ABX +1.2% (upgraded to Outperform from Sector Perform at RBC Capital), CAT +0.3% (initiated with a Buy at Deutsche Bank)
M&A news: JNPR +2.9% (Nokia considering acquisition of JNPR, according to reports ).
Select oil/gas related names showing strength: SNP +2.9%, DO +1.6%, COP +1.0%, BP +1%, RDS.A +0.6%, SDRL +0.6%, PBR +0.6%, CVX +0.4%.
A few biotech/pharma names are higher: MRK +1.1%, AZN +1%, BMY +1.0%, GSK +1.0%
FB/WhatsApp news lifting select tech names/peers: MEET +13.1% BBRY +4.9% TWTR +0.5%
Other news: RPTP +7.2% (Announces Clinical Results With RP103 in Huntington's Disease Phase 2/3 Trial; 18 Month Clinical Results Showed Significantly Slower Progression of Total Motor Score in RP103 Treated Patients Without Tetrabenazine), ATRS +5.5% (announces positive results from the VIBEX QuickShot pharmacokinetic study in testosterone deficient men; rapid restoration and consistent maintenance of steady testosterone blood levels achieved with once-weekly subcutaneous administration using the QuickShot auto injector), KNDI +4.1% (TSLA sympathy), VE +3.3% (Veolia Environnement higher on contract win news), GRPN +2.8% (ahead of earnings after the close), SCTY +2.6% (TSLA/Musk sympathy), OMG +1.7% (OM Group company EaglePicher Technologies receives contract from Erigo Technologies to deliver a Flexible Microgrid Energy Storage System for DoD applications), SVU +1.3% (following SWY results and news), WRB +0.6% (increases share repurchase authorization back to its previous level of 10 mln shares of common stock), ALL +0.6% (increases quarterly dividend 12% to $0.28 from $0.24 per share; launches $2.5 bln common stock repurchase program), PCLN +0.5% and CTRP +0.5% (following AWAY results), NXPI +0.4% (repurchases 5 mln shs of common stock ), KR +0.3% (following SWY results and news).
Analyst comments: BLOX +3.2% (upgraded to Buy from Neutral at Goldman), BCRX +2.8% (initiated with a Buy at Mizuho; tgt $23 ), HSTM +1.4% (upgraded to Overweight from Equal Weight at First Analysis), G +1.3% (initiated with an Overweight at Piper Jaffray), ABX +1.2% (upgraded to Outperform from Sector Perform at RBC Capital), CAT +0.3% (initiated with a Buy at Deutsche Bank)